Methylphenidate Patch
Product Images NDC 0378-8261

This is a diagram showing the components of a drug product. The drug product consists of three layers, an outside backing layer, a solid matrix drug reservoir layer, and an adhesive formulation layer. There is also a protective liner layer that needs to be removed before applying the product. However, without additional context, the specific purpose and use of this drug product cannot be determined.*

This appears to be a mixture of different types of text, including letters, numbers, symbols, and product information. Some of the text seems to refer to a transdermal system that delivers 10 mg of methylphenidate over 9 hours and contains 30 systems per package. The system is for transdermal use only and should be worn for approximately 9 hours. Each system contains 10.4 mg of methylphenidate, and the active ingredient release is limited. The text also mentions recommended dosing, patient instructions, disposal information, and that a medication guide should be dispensed to each patient by a pharmacist. There is other text that is not clear and seems unrelated to the product information, such as a list of "systems," characters, and symbols.*

This is a product description for a Transdermal System delivering Methylphenidate. The package contains 30 systems and is meant for transdermal use only, with each system releasing 15mg of Methylphenidate over 9 hours (1.6 mg/hr). The package also includes a Medication Guide for each patient and instructions for disposal. There is some unreadable text that cannot be understood.*

This is a description of a methylphenidate transdermal system that delivers 20 mg of the active ingredient over 9 hours. Each system contains 20.7 mg of methylphenidate and there are 30 systems per package. The recommended dosing and patient instructions are available in the package. The product should be kept out of the reach of children and the patient instructions provide guidance on disposal. The NDC code is 0378-8262-93, and it is manufactured by Mylan.*

This appears to be a chart or graph displaying the concentration of d-Methylphenidate (a medication used to treat ADHD) in ng/mL over time (in hours) after applied with a transdermal system. The concentration peaks at around 20 ng/mL around 8 hours after application, then gradually decreases over time.*

This is a description of a medication containing Methylphenidate. It is a Transdermal system that delivers 30mg over 9 hours (3.3mg/hr). The package contains 30 systems, and the NDC code is 0378-8263-93. The product has patient instructions to follow and should only be applied to the skin. The accompanying medication guide should be given to the patient, and it's important to keep the product out of the reach of children. The rest of the text contains jumbled letters and is not readable.*